Valuation: Certara, Inc.

Market Cap 1.55B 1.38B 1.27B 1.16B 2.17B 147B 2.21B 15.38B 6.05B 77.2B 5.83B 5.7B 243B P/E 2026 *
-45.9x
P/E 2027 * 172x
Enterprise Value 1.61B 1.44B 1.32B 1.2B 2.26B 153B 2.3B 15.97B 6.29B 80.17B 6.05B 5.92B 253B EV / Sales 2026 *
4.25x
EV / Sales 2027 * 3.94x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-0.88%
1 week+7.80%
Current month+9.67%
1 month+18.43%
3 months+47.30%
6 months+62.74%
Current year+14.53%
1 week 9.22
Extreme 9.215
10.31
1 month 8.52
Extreme 8.52
10.31
Current year 4.45
Extreme 4.45
10.31
1 year 4.45
Extreme 4.45
12.94
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO 53 2026-07-14
Chief Tech/Sci/R&D Officer - 2025-07-30
Director TitleAgeSince
Chairman 72 2021-11-30
Director/Board Member 68 2012-12-31
Director/Board Member 59 2017-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Chief Financial Officer

63,532 0.0416%
7/15/26 Other

Chief Financial Officer

191,850 0.1233%
6/1/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%+7.80%-17.77%-25.31% 1.55B
-2.23%-2.36%+0.66%+59.51% 3,957B
-2.74%-2.38%+8.09%+1,117.82% 485B
-2.78%-3.84%-54.37%+23.26% 391B
+2.21%-5.36%+65.54%+192.00% 284B
+3.21%+9.35%-10.42%+73.78% 270B
-0.58%-4.55%+88.86%+432.42% 246B
+2.53%+12.16%-16.62%+44.70% 158B
-0.61%-6.01%+104.03%+206.92% 128B
+6.07%+12.41%-24.33%-49.99% 99.27B
Average +0.01%+1.04%+14.37%+207.51% 602.04B
Weighted average by Cap. +0.12%-1.45%+5.16%+165.38%

Financials

2026 *2027 *
Net sales 379M 338M 311M 283M 531M 35.94B 540M 3.75B 1.48B 18.85B 1.42B 1.39B 59.42B 389M 347M 319M 290M 545M 36.86B 554M 3.85B 1.52B 19.33B 1.46B 1.43B 60.94B
Net income -30.79M -27.44M -25.25M -22.97M -43.12M -2.92B -43.87M -305M -120M -1.53B -116M -113M -4.83B 4.22M 3.76M 3.46M 3.15M 5.91M 400M 6.02M 41.8M 16.46M 210M 15.84M 15.51M 662M
Net Debt 59.79M 53.29M 49.04M 44.61M 83.73M 5.67B 85.18M 592M 233M 2.97B 224M 220M 9.37B -19.92M -17.76M -16.34M -14.87M -27.9M -1.89B -28.38M -197M -77.65M -990M -74.74M -73.17M -3.12B
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
26-10-22 US$10.09 -0.88% 2,364,892
26-10-21 US$10.18 +4.04% 1,717,477
26-10-20 US$9.785 +3.54% 2,784,588
26-10-19 US$9.450 +0.85% 1,504,652
26-10-16 US$9.370 -3.00% 2,359,261
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.18USD
Average target price
9.168USD
Spread / Average Target
-9.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock